Paid Clinical Trials for Hypopharyngeal Squamous Cell Carcinoma

  1. Home
  2. Jobs
  3. Hypopharyngeal Squamous Cell Carcinoma
Showing all 2 results

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

by CTG
in Head and Neck Squamous Cell Carcinoma, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Hypopharyngeal Squamous Cell Carcinoma
Other
Arizona
Deadline:
01/01/2027